Rilzabrutinib 12522-3331
Product NDC
12522-3331- Manufacturer
- Sanofi S.r.l.
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- August 29, 2025
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rilzabrutinib | 400 mg/1 |
Packaging Options(2)
16 KIT in 1 BOX (12522-3331-2) / 2 DOSE PACK in 1 KIT / 2 BLISTER PACK in 1 DOSE PACK / 14 TABLET, FILM COATED in 1 BLISTER PACK
84 CARTON in 1 BOX (12522-3331-4) / 1 BOTTLE in 1 CARTON / 60 TABLET, FILM COATED in 1 BOTTLE